🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron food interaction profile — 12 month update Page 4

Orforglipron food interaction profile — 12 month update

hyun_seoul Sun, Mar 16, 2025 at 3:01 AM 33 replies 2,175 viewsPage 4 of 7
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Apr 3, 2025 at 1:18 AM#16

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

That is the short version; the long version is somebody else's post.

Last edited: Apr 3, 2025 at 3:18 AM
10 8FitDadDave, RunnerRach, TrialNerd_Beth and 7 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Apr 5, 2025 at 3:30 PM#17

One thing that is still open after TomTeleRx’s answer:

Was that from a primary source or from a summary of one?

Last edited: Apr 5, 2025 at 6:30 PM
11 9MounjBrad, nick_newbie, DadBodDave and 8 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Apr 8, 2025 at 5:44 AM#18
Dr.AddMedPHL said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

This is where I part company with the consensus forming above. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

12 10Dr.SleepRoch, laura_annarbor, JenMemphis and 9 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Apr 10, 2025 at 7:59 PM#19
Dr.AddMedPHL said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

13 11roxy_nash, tony_orlando, Dr.NephBHM_UK and 10 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 13, 2025 at 10:15 AM#20

Moderator note: a couple of off-topic posts removed.

35 8PurityPaulOR, MaxMetOK, MounjBrad and 32 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register